VMD-928

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameVMD-928
Drug Alias NameVMD-928
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVm Oncology Llc
China Registration ClassN/A

Develop Information

Active CompaniesVm Oncology Llc
Inactive CompaniesN/A
Active IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A